• Home
    • Concept
  • Program
    • Speakers
  • PneumoLive
  • Livestream
  • On-demand
  • Partners
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration
info@medupdate-europe.eu
Login

Login
Pneumo Update Europe 2023Pneumo Update Europe 2023
Pneumo Update Europe 2023
23 - 24 June - Amsterdam & Virtual
  • Home
    • Concept
  • Program
    • Speakers
  • PneumoLive
  • Livestream
  • On-demand
  • Partners
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration

Partners

More Information

CSL Behring’s portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.

Check here for more information about www.cslbehring.com

Watch past symposia here!

Looking for the 'zebras' among the horses in common respiratory disorders: could it be something else?

Sharing important insights: what we learnt from Covid-19

More Information

Boehringer Ingelheim has over 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

Check here for more information about www.boehringer-ingelheim.com

In cooperation with
Submit an Abstract! Register Here!

Accreditation – EACCME & EBAP

The Pneumo Update Europe 2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9 European CME credits (ECMEC®s).

The PUE23  has been found worthy of accreditation by the European Board for Accreditation in Pneumology (EBAP) for 9.5 CME credits covering the whole program.

EBAP reviewers have awarded the Mark of Excellence (MOE) for this activity which is worth an extra 4 CME credits. An MOE is given to activities with exceptionally high quality and standards.

Accreditation – EFPIA & Ethical Medtech

The Pneumo Update Europe 2023 has been assessed COMPLIANT by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the MedTech Europe Code of Ethical Business Practice.

 

Follow us

Newsletter Subscription

Click here to receive news about your interest area. Unsubscribe at any time.

ethical medtech

www.ethicalmedtech.eu

© 2023

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}